C-Reactive Protein 1059G>C Genetic Polymorphism Influences Serum C-Reactive Protein Levels after Esophagectomy in Patients with Thoracic Esophageal Cancer

Journal of the American College of Surgeons

Volumn 209, Issue 4, 2009, Pages 477-483

  Motoyama, Satoru ^a   Miura, Masatomo ^b   Hinai, Yudai ^b   Maruyama, Kiyotomi ^a   Usami, Shuetsu ^a   Nakatsu, Toshinobu ^a   Saito, Hajime ^a   Minamiya, Yoshihiro ^a   Suzuki, Toshio ^b   Ogawa, Jun ichi ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARCINOMA, SQUAMOUS CELL; CYSTEINE; CYTOKINES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GENOTYPE; GLYCINE; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE PERIOD; TUMOR MARKERS, BIOLOGICAL;

EID: 70349412939     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2009.06.365     Document Type: Article

References (39)

1. Marnell L., Mold C., and Du Clos T.W. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 117 (2005) 104-111
2. Black S., Kushner I., and Samols D. C-reactive protein. J Biol Chem 279 (2004) 48487-48490
3. Young B., Gleeson M., and Cripps A.W. C-reactive protein: a critical review. Pathology 23 (1991) 118-124
4. Morris-Stiff G., Gomez D., and Prasad K.R. C-reactive protein in liver cancer surgery. Eur J Surg Oncol 34 (2008) 727-729
5. Shimada H., Nabeya Y., Okazumi S., et al. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol 83 (2003) 248-252
6. Hashimoto K., Ikeda Y., Korenaga D., et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103 (2005) 1856-1864
7. Wolford J.K., Gruber J.D., Ossowski V.M., et al. A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol Genet Metab 78 (2003) 136-144
8. Russell A.I., Cunninghame Graham D.S., Shepherd C., et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13 (2004) 137-147
9. Eklund C., Kivimäki M., Islam M.S., et al. C-reactive protein genetics is associated with carotid artery compliance in men in The Cardiovascular Risk in Young Finns Study. Atherosclerosis 196 (2008) 841-848
10. Day C.P., Grove J., Daly A.K., et al. Tumor necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 41 (1998) 430-434
11. Skoog T., van't Hooft F.M., Kallin B., et al. A common functional polymorphism (C->A substitution at position -863) in the promoter region of the tumor necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 8 (1999) 1443-1449
12. Kim T.G., Kim H.Y., Lee S.H., et al. Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean population. Hum Immunol 46 (1996) 10-17
13. Pravica V., Perrey C., Stevens A., et al. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61 (2000) 863-866
14. Shu X.O., Gao Y.T., Cai Q., et al. Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. Cancer Res 64 (2004) 836-839
15. Graziano F., Ruzzo A., Santini D., et al. Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer. J Clin Oncol 23 (2005) 2339-2345
16. Lehtimäki T., Laaksonen R., Janatuinen T., et al. Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men. Pharmacogenetics 13 (2003) 633-639
17. Graziano F., Ruzzo A., Santini D., et al. Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer. J Clin Oncol 23 (2005) 2339-2345
18. Ross O.A., Curran M.D., Meenagh A., et al. Study of age-association with cytokine gene polymorphisms in an aged Irish population. Mech Ageing Dev 124 (2003) 199-206
19. Noguchi E., Shibasaki M., Arinami T., et al. Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy 28 (1998) 449-453
20. Buraczynska M., Jozwiak L., Ksiazek P., et al. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis. Transl Res 150 (2007) 101-105
21. Wolford J.K., Colligan P.B., Gruber J.D., and Bogardus C. Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians. Mol Genet Metab 80 (2003) 338-343
22. Edwards-Smith C.J., Jonsson J.R., Purdie D.M., et al. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 30 (1999) 526-530
23. Hall M.A., McGlinn E., Coakley G., et al. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 1 (2000) 219-224
24. Tillett W.S., and Francis Jr. T. Serological reactions in pneumonia with a non-protein fraction of pneumococcus. J Exp Med 52 (1930) 561-571
25. Carlson C.S., Aldred S.F., Lee P.K., et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 77 (2005) 64-77
26. Lange L.A., Carlson C.S., Hindorff L.A., et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 296 (2006) 2703-2711
27. Miller D.T., Zee R.Y., Suk Danik J., et al. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 69 (2005) 623-638
28. Siemes C., Visser L.E., Coebergh J.W., et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 24 (2006) 5216-5222
29. Wen W., Cai Q., Xiang Y.B., et al. The modifying effect of C-reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk. Cancer 112 (2008) 2409-2416
30. Szalai A.J., Briles D.E., and Volanakis J.E. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol 155 (1995) 2557-2563
31. Mold C., Rodic-Polic B., and Du Clos T.W. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fcγ receptors. J Immunol 168 (2002) 6375-6381
32. Szalai A.J., VanCott J.L., McGhee J.R., et al. Human C-reactive protein is protective against fatal Salmonella enterica Serovar Typhimurium infection in transgenic mice. Infect Immun 68 (2000) 5652-5656
33. Mold C., Rodriguez W., Rodic-Polic B., and Du Clos T.W. C-reactive protein mediates protection from lipopolysaccharide through interactions with FcγR. J Immunol 169 (2002) 7019-7025
34. Tilg H., Vannier E., Vachino G., et al. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of Interleukin 1 (IL-1) receptor antagonist over IL-1b synthesis by human peripheral blood mononuclear cells. J Exp Med 178 (1993) 1629-1636
35. Brull D.J., Serrano N., Zito F., et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23 (2003) 2063-2069
36. Russell A.I., Graham D.S.C., Shepherd C., et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13 (2004) 137-147
37. Suk H.J., Ridker P.M., Cook N.R., and Zee R.Y. Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 178 (2005) 139-145
38. Zee R.Y., and Ridker P.M. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162 (2002) 217-219
39. Eklund C., Lehtimaki T., and Hurme M. Epistatic effect of C-reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin-1B SNP +3954 on CRP concentration in healthy male blood donors. Int J Immunogenet 32 (2005) 229-232